Specificity of human complement factor H-related protein test (Bard BTA stat Test)

Scandinavian Journal of Urology and Nephrology

Volumn 33, Issue 4, 1999, Pages 234-236

  Raitanen, Mika P ^a,b   Tammela, Teuvo L J ^b  

^a SEINÄJOKI CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Bladder neoplasms; Cytology; Diagnosis; Monitoring; Screening; Tumour marker

Indexed keywords

COMPLEMENT FACTOR H; TUMOR ANTIGEN; TUMOR MARKER;

ADULT; ARTICLE; BLADDER CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER SCREENING; CYSTOSCOPY; ECHOGRAPHY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS UROGRAPHY; LABORATORY TEST; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URINE;

ADULT; ANTIGENS, NEOPLASM; COMPLEMENT FACTOR H; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL; URINARY BLADDER NEOPLASMS;

EID: 0032841894     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655999750015835     Document Type: Article

References (13)

1. Murphy W. Current status of urinary cytology in evaluation of bladder neoplasms. Hum Pathol 1990; 21: 886-96.
2. Sarasdy MF, De Vere White RW, Soloway MS, Sheinfeld J, Hudson MA, Schellhammer PF, et al. Results of a multicenter trial using the BTA test to monitor for and diagnose recurrent bladder carcinoma. J Urol 1995; 154: 379-84.
3. Umiker W. Accuracy of cytological diagnosis of cancer of the urinary tract. Acta Cytol 1964; 8: 186-96.
4. Sarosdy M, Hudson M, Ellis WJ, Soloway MS, de Vere White R, Sheinfeld J, et al. Improved detection of recurrent bladder cancer using the Bard BTA stat Test. Urology 1997; 50: 349-53.
5. Kinders R, Root R, Jones J, Bruce C, Hass M. Complement factor H-related proteins are expressed in bladder cancer [abstract 189]. Proceedings of the 88th Annual Meeting of the American Association for Cancer Research, San Diego, CA, USA, 1997; 38: 29.
6. Kinders R, Jones J, Root R, Murchison H, Bruce C, Williams L, et al. Human bladder tumour antigen is a member of the RCA (regulators of complement activation) gene family [abstract 110]. J Urol 1997; 157(Suppl 4): 28.
7. Messing E, Vallaincourt A. Hematuria screening for bladder cancer. J Occup Med 1990; 32: 838-45.
8. Messing E, Young T, Hunt VB, Gilchrist KW, Newton MA, Bram LL, et al. Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations. Urology 1995; 45: 387-97.
9. Britton P, Dowell A, Whelan P, Harris C. A community study of bladder cancer screening by the detection of occult urinary bleeding. J Urol 1992; 148: 788-90.
10. Heney NM, Nocka BN, Daly JJ, Prout Jr GR, Newall JB, Griffin BB, et al. Ta and T1 bladder cancer: location, recurrence and progression. Br J Urol 1982; 54: 152-7.
11. Lutzeyer W, Rubben H, Dahm H. Prognostic parameters in superficial bladder cancer: an analysis of 315 cases. J Urol 1982; 127: 250-2.
12. Thompson RA, Campbell Jr EW, Kramer HC, Jacobs SC, Naslund MJ. Late invasive recurrence despite long-term surveillance for superficial bladder cancer. J Urol 1993; 149: 1010-1.
13. Anttila A, Auvinen A, Hakama M, Hakulinen T, Koivusalo M, Lehtonen M. et al. Cancer incidence in Finland 1995. Finnish Cancer Registry 1997, Helsinki, Finland.